Literature DB >> 25949223

Dependence of the safe rectum dose on the CTV-PTV margin size and treatment technique.

Pawel Kukołowicz1, Helena Kukołowicz1, Izabela Tyburska1.   

Abstract

BACKGROUND: Late rectal injury is a common side effect of external beam radiotherapy for prostate cancer. AIM: The aim of this study was to evaluate what total dose may be safely delivered for prostate patients for 3DCRT and IMRT techniques and the CTV-PTV margin.
MATERIALS AND METHODS: 3DCRT and IMRT plans were prepared for 12 patients. For each patient PTV was defined with CTV-PTV margins of 0.4, 0.6, …, 1.0 cm, and total doses of 70, 72, …, 80 Gy, with 2 Gy dose fraction. NTCP values for the rectum were calculated using the Lyman model. Both techniques were compared in terms of population mean DVH.
RESULTS: Significantly smaller NTCPs for IMRT were obtained. For both techniques diminishing the margin CTV-PTV of 2 mm leads to decreasing the NTCP of about 0.03. For total dose of 80 Gy the NTCP was smaller than 10% for the 4 mm margin only. The QUANTEC dose volume constraints were more frequently fulfilled for the IMRT technique than for the 3DCRT technique.
CONCLUSIONS: The IMRT technique is safer for prostate patients than the 3DCRT. If very high total doses are applied the CTV-PTV margin of 0.4 cm and the IMRT technique should be used. If the CTV-PTV margin of 0.6 cm is applied, the NTCP is smaller than 10% for the 3DCRT and IMRT techniques for the total doses smaller than 74 Gy and 78 Gy, respectively.

Entities:  

Keywords:  3DCRT and IMRT; CTV–PTV margin; Normal Tissue Complication Probability; Rectum injury

Year:  2015        PMID: 25949223      PMCID: PMC4418584          DOI: 10.1016/j.rpor.2014.12.004

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  22 in total

Review 1.  Is there a role for endorectal balloons in prostate radiotherapy? A systematic review.

Authors:  Robert Jan Smeenk; Bin S Teh; E Brian Butler; Emile N J Th van Lin; Johannes H A M Kaanders
Journal:  Radiother Oncol       Date:  2010-05-05       Impact factor: 6.280

2.  Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations.

Authors:  G J Kutcher; C Burman; L Brewster; M Goitein; R Mohan
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-05-15       Impact factor: 7.038

3.  Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes.

Authors:  Michael J Zelefsky; Xin Pei; Joanne F Chou; Michael Schechter; Marisa Kollmeier; Brett Cox; Yoshiya Yamada; Anthony Fidaleo; Dahlia Sperling; Laura Happersett; Zhigang Zhang
Journal:  Eur Urol       Date:  2011-08-22       Impact factor: 20.096

4.  Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer. Matched-pair analysis.

Authors:  M Pinkawa; M D Piroth; R Holy; N Escobar-Corral; M Caffaro; V Djukic; J Klotz; M J Eble
Journal:  Strahlenther Onkol       Date:  2012-08-31       Impact factor: 3.621

5.  Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A Test of the QUANTEC-recommended NTCP model.

Authors:  Mitchell Liu; Vitali Moiseenko; Alexander Agranovich; Anand Karvat; Winkle Kwan; Ziad H Saleh; Aditya A Apte; Joseph O Deasy
Journal:  Acta Oncol       Date:  2010-10       Impact factor: 4.089

6.  Evidence of increased failure in the treatment of prostate carcinoma patients who have perineural invasion treated with three-dimensional conformal radiation therapy.

Authors:  S R Bonin; A L Hanlon; W R Lee; B Movsas; T I al-Saleem; G E Hanks
Journal:  Cancer       Date:  1997-01-01       Impact factor: 6.860

7.  Residual translational and rotational errors after kV X-ray image-guided correction of prostate location using implanted fiducials.

Authors:  Reinhold Graf; Dirk Boehmer; Volker Budach; Peter Wust
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

8.  Comparative analysis of image guidance in two institutions for prostate cancer patients.

Authors:  Tomasz Piotrowski; Slav Yartsev; George Rodrigues; Tomasz Bajon
Journal:  Rep Pract Oncol Radiother       Date:  2014-01-02

9.  Observations on real-time prostate gland motion using electromagnetic tracking.

Authors:  Katja M Langen; Twyla R Willoughby; Sanford L Meeks; Anand Santhanam; Alexis Cunningham; Lisa Levine; Patrick A Kupelian
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-02-14       Impact factor: 7.038

10.  A verification procedure to improve patient set-up accuracy using portal images.

Authors:  A Bel; M van Herk; H Bartelink; J V Lebesque
Journal:  Radiother Oncol       Date:  1993-11       Impact factor: 6.280

View more
  1 in total

1.  Image-guided hypofractionated proton beam therapy for low-risk prostate cancer: Analysis of quality of life and toxicity, PCG GU 002.

Authors:  Carlos Enrique Vargas; William Fred Hartsell; Megan Dunn; Sameer Ramchandra Keole; Lucius Doh; John Chang; Gary Lynn Larson
Journal:  Rep Pract Oncol Radiother       Date:  2016-03-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.